These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11050782)

  • 21. Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers.
    Morrell J
    BMJ; 1999 May; 318(7195):1419-20. PubMed ID: 10334767
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid-lowering drug therapy in elderly patients.
    Berthold HK; Gouni-Berthold I
    Curr Pharm Des; 2011; 17(9):877-93. PubMed ID: 21418034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins for stroke: the second story?
    Plutzky J; Ridker PM
    Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins: is there a need for alternative or adjunctive therapy?
    Shepherd J
    Br Heart J; 1995 Jul; 74(1):13. PubMed ID: 7662445
    [No Abstract]   [Full Text] [Related]  

  • 25. DoH explains thinking behind national service framework for coronary heart disease.
    Boyle R
    BMJ; 2000 Oct; 321(7268):1083. PubMed ID: 11053200
    [No Abstract]   [Full Text] [Related]  

  • 26. A tale of two trials: The West of Scotland Coronary Prevention Study and the Texas Coronary Atherosclerosis Prevention Study.
    Shepherd J
    Atherosclerosis; 1998 Aug; 139(2):223-9. PubMed ID: 9712327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid-lowering therapy for elderly patients at risk for coronary events and stroke.
    Courville KA; Lavie CJ; Milani RV
    Am Heart Hosp J; 2005; 3(4):256-62. PubMed ID: 16330918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
    Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
    [No Abstract]   [Full Text] [Related]  

  • 29. New British recommendations for prevention of coronary heart disease in clinical practice.
    Faergeman O
    Heart; 1999 Apr; 81(4):335. PubMed ID: 10092555
    [No Abstract]   [Full Text] [Related]  

  • 30. New evidence, new guidelines.
    Shepherd J
    Atherosclerosis; 1998 Oct; 140(2):197-8. PubMed ID: 9862268
    [No Abstract]   [Full Text] [Related]  

  • 31. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U; Weintraub WS; Packard CJ
    Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of lipid-lowering therapy in preventing coronary heart disease in patients with type 2 diabetes.
    Karalis DG
    Clin Cardiol; 2008 Jun; 31(6):241-8. PubMed ID: 17847038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins: effects beyond cholesterol lowering.
    Massy ZA; Guijarro C
    Nephrol Dial Transplant; 2001 Sep; 16(9):1738-41. PubMed ID: 11522848
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduction of coronary events: evidence from clinical trials.
    Gotto AM
    Curr Opin Lipidol; 1995 Dec; 6(6):345-7. PubMed ID: 8750245
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins.
    Pearson TA
    Am J Cardiol; 1998 Nov; 82(10A):28S-30S. PubMed ID: 9860353
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipid-lowering for prevention of coronary heart disease: what policy now?
    Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN
    Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antilipemic agents and evidence based medicine].
    Plata MC
    Med Clin (Barc); 2001 Mar; 116(10):397-8. PubMed ID: 11333681
    [No Abstract]   [Full Text] [Related]  

  • 39. Statins prevent coronary heart disease.
    Oliver MF
    Lancet; 1995 Nov; 346(8987):1378-9. PubMed ID: 7475814
    [No Abstract]   [Full Text] [Related]  

  • 40. Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes.
    Gami AS; Montori VM; Erwin PJ; Khan MA; Smith SA;
    BMJ; 2003 Mar; 326(7388):528-9. PubMed ID: 12623912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.